Zobrazeno 1 - 10
of 416
pro vyhledávání: '"Left ventricle hypertrophy"'
Publikováno v:
Zaporožskij Medicinskij Žurnal, Vol 26, Iss 4, Pp 350-354 (2024)
Aim. To describe a clinical case and analyze the challenges in diagnosing hypertrophic cardiomyopathy (HCM) in a patient with concomitant arterial hypertension (AH). Materials and methods. The article presents the clinical case of HCM in the patie
Externí odkaz:
https://doaj.org/article/213d79ebf88149d7bbc4ed278b66c78b
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background and Aims Sodium-glucose co-transporter 2 (SGLT2) inhibitors have beneficial effects in heart failure (HF), including reverse remodelling, but the mechanisms by which these benefits are conferred are unclear. Inflammation is implic
Externí odkaz:
https://doaj.org/article/33a82ecb2bdf4a93a0f66ac54313e311
Novel Genetics and Humoral Prognostic Markers of Left Ventricle Hypertrophy in Hypertensive Patients
Autor:
Kseniia Voroniuk, Larysa Sydorchuk, Yuliya Repchuk, Andrii Sydorchuk, Ruslan Sydorchuk, Oksana Iftoda
Publikováno v:
Journal of Medical Sciences, Vol 44, Iss 1, Pp 18-25 (2024)
Background: Left ventricular hypertrophy (LVH) is not only complications or the damaged appearance of the target organ of patients with essential arterial hypertension (EAH), but at the same time, it is also a prognostic factor. Aim: The aim is to ev
Externí odkaz:
https://doaj.org/article/063edf9117ef49edb55b5cd0b579b5ea
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
Fibroblast growth factor (FGF)23 is a bone-derived phosphotropic hormone that regulates phosphate and mineral homeostasis. Recent studies have provided evidence that a high plasma concentration of FGF23 is associated with cardiac disease, including l
Externí odkaz:
https://doaj.org/article/bf1dc357267a476096c3230761fda3a3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ines Paola Monte, Denise Cristiana Faro, Giancarlo Trimarchi, Fabrizio de Gaetano, Mariapaola Campisi, Valentina Losi, Lucio Teresi, Gianluca Di Bella, Corrado Tamburino, Cesare de Gregorio
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 10, Iss 6, p 261 (2023)
Background: Left atrial (LA) function is crucial for assessing left ventricular filling in various cardiovascular conditions. Cardiac Amyloidosis (CA) is characterized by atrial myopathy and LA function impairment, with diastolic dysfunction up to re
Externí odkaz:
https://doaj.org/article/f9beb8341b5040ba90996ceb586fefae
Publikováno v:
Clinical and Experimental Hypertension, Vol 43, Iss 5, Pp 428-435 (2021)
Salt-inducible kinases (SIKs) represent a subfamily of AMPK family kinases. SIK1 has been shown to act as a mediator during the cellular adaptation to variations in intracellular sodium in a variety of cell types. SIK2, as an isoform of the SIK famil
Externí odkaz:
https://doaj.org/article/c5dd2429334345bca42fe373c73e695c
Publikováno v:
Clinical and Experimental Hypertension, Vol 43, Iss 2, Pp 142-150 (2021)
Objective To explore the effect of renal sympathetic denervation (RSD) on left ventricle hypertrophy and the Raf/MEK/ERK signaling pathway in spontaneously hypertensive rats (SHRs). Methods SHRs were divided into SHR, SHR + Sham, SHR + RSD and SHR +
Externí odkaz:
https://doaj.org/article/57d66dad41484e7f90d0f7f1d9e2c705
Autor:
Ö. Çağlar Yılmaz, Selçuk Özkan
Publikováno v:
Clinical and Experimental Hypertension, Vol 43, Iss 2, Pp 138-141 (2021)
Objectives Unexplained left ventricular hypertrophy (ULVH) is defined as increased wall thickness in the absence of conditions that predispose to hypertrophy. The aim of this study was to evaluate the rate of masked hypertension in patient with unexp
Externí odkaz:
https://doaj.org/article/dd290ec7009244939cd6e4875ee71fde